Application of deep learning technique to manage COVID-19 in routine clinical practice using CT images: Results of 10 convolutional neural networks

Multicenter Assessment of CT Pneumonia Analysis Prototype for Predicting Disease Severity and Patient Outcome

To perform a multicenter assessment of the CT Pneumonia Analysis prototype for predicting disease severity and patient outcome in COVID-19 pneumonia both without and with integration of clinical information. Our IRB-approved observational study included consecutive 241 adult patients (> 18 years; 105 females; 136 males) with RT-PCR-positive COVID-19 pneumonia who underwent non-contrast chest CT at one of the two tertiary care hospitals (site A: Massachusetts General Hospital, USA; site B: Firoozgar Hospital Iran). We recorded patient age, gender, comorbid conditions, laboratory values, intensive care unit (ICU) admission, mechanical ventilation, and final outcome (recovery or death). Two thoracic radiologists reviewed all chest CTs to record type, extent of pulmonary opacities based on the percentage of lobe involved, and severity of respiratory motion artifacts. Thin-section CT images were processed with the prototype (Siemens Healthineers) to obtain quantitative features including lung volumes, volume and percentage of all-type and high-attenuation opacities (≥ -200 HU), and mean HU and standard deviation of opacities within a given lung region. These values are estimated for the total combined lung volume, and separately for each lung and each lung lobe. Multivariable analyses of variance (MANOVA) and multiple logistic regression were performed for data analyses. About 26% of chest CTs (62/241) had moderate to severe motion artifacts. There were no significant differences in the AUCs of quantitative features for predicting disease severity with and without motion artifacts (AUC 0.94-0.97) as well as for predicting patient outcome (AUC 0.7-0.77) (p > 0.5). Combination of the volume of all-attenuation opacities and the percentage of high-attenuation opacities (AUC 0.76-0.82, 95% confidence interval (CI) 0.73-0.82) had higher AUC for predicting ICU admission than the subjective severity scores (AUC 0.69-0.77, 95% CI 0.69-0.81). Despite a high frequency of motion artifacts, quantitative features of pulmonary opacities from chest CT can help differentiate patients with favorable and adverse outcomes.

Efficient COVID-19 Segmentation from CT Slices Exploiting Semantic Segmentation with Integrated Attention Mechanism

Coronavirus (COVID-19) is a pandemic, which caused suddenly unexplained pneumonia cases and caused a devastating effect on global public health. Computerized tomography (CT) is one of the most effective tools for COVID-19 screening. Since some specific patterns such as bilateral, peripheral, and basal predominant ground-glass opacity, multifocal patchy consolidation, crazy-paving pattern with a peripheral distribution can be observed in CT images and these patterns have been declared as the findings of COVID-19 infection. For patient monitoring, diagnosis and segmentation of COVID-19, which spreads into the lung, expeditiously and accurately from CT, will provide vital information about the stage of the disease. In this work, we proposed a SegNet-based network using the attention gate (AG) mechanism for the automatic segmentation of COVID-19 regions in CT images. AGs can be easily integrated into standard convolutional neural network (CNN) architectures with a minimum computing load as well as increasing model precision and predictive accuracy. Besides, the success of the proposed network has been evaluated based on dice, Tversky, and focal Tversky loss functions to deal with low sensitivity arising from the small lesions. The experiments were carried out using a fivefold cross-validation technique on a COVID-19 CT segmentation database containing 473 CT images. The obtained sensitivity, specificity, and dice scores were reported as 92.73%, 99.51%, and 89.61%, respectively. The superiority of the proposed method has been highlighted by comparing with the results reported in previous studies and it is thought that it will be an auxiliary tool that accurately detects automatic COVID-19 regions from CT images.

A Hybrid Model for COVID-19 Monitoring and Prediction

COVID-19 is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has a case-fatality rate of 2–3%, with higher rates among elderly patients and patients with comorbidities. Radiologically, COVID-19 is characterised by multifocal ground-glass opacities, even for patients with mild disease. Clinically, patients with COVID-19 present respiratory symptoms, which are very similar to other respiratory virus infections. Our knowledge regarding the SARS-CoV-2 virus is still very limited. These facts make it vitally important to establish mechanisms that allow to model and predict the evolution of the virus and to analyze the spread of cases under different circumstances. The objective of this article is to present a model developed for the evolution of COVID in the city of Manizales, capital of the Department of Caldas, Colombia, focusing on the methodology used to allow its application to other cases, as well as on the monitoring tools developed for this purpose. This methodology is based on a hybrid model which combines the population dynamics of the SIR model of differential equations with extrapolations based on recurrent neural networks. This combination provides self-explanatory results in terms of a coefficient that fluctuates with the restraint measures, which may be further refined by expert rules that capture the expected changes in such measures.

Helping Roles of Artificial Intelligence (AI) in the Screening and Evaluation of COVID-19 Based on the CT Images

Objective

The aim of this study was to explore the role of the AI system which was designed and developed based on the characteristics of COVID-19 CT images in the screening and evaluation of COVID-19.

Methods

The research team adopted an improved U-shaped neural network to segment lungs and pneumonia lesions in CT images through multilayer convolution iterations. Then the appropriate 159 cases were selected to establish and train the model, and Dice loss function and Adam optimizer were used for network training with the initial learning rate of 0.001. Finally, 39 cases (29 positive and 10 negative) were selected for the comparative test. Experimental group: an attending physician a and an associate chief physician a read the CT images to diagnose COVID-19 with the help of the AI system. Control group: an attending physician b and an associate chief physician b did the diagnosis only by their experience, without the help of the AI system. The time spent by each doctor in the diagnosis and their diagnostic results were recorded. Paired t-test, univariate ANOVA, chi-squared test, receiver operating characteristic curves, and logistic regression analysis were used for the statistical analysis.

Results

There was statistical significance in the time spent in the diagnosis of different groups (P<0.05). For the group with the optimal diagnostic results, univariate and multivariate analyses both suggested no significant correlation for all variables, and thus it might be the assistance of the AI system, the epidemiological history and other factors that played an important role.

Conclusion

The AI system developed by us, which was created due to COVID-19, had certain clinical practicability and was worth popularizing.

Application of Machine Learning in Diagnosis of COVID-19 Through X-Ray and CT Images: A Scoping Review

Coronavirus disease, first detected in late 2019 (COVID-19), has spread fast throughout the world, leading to high mortality. This condition can be diagnosed using RT-PCR technique on nasopharyngeal and throat swabs with sensitivity values ranging from 30 to 70%. However, chest CT scans and X-ray images have been reported to have sensitivity values of 98 and 69%, respectively. The application of machine learning methods on CT and X-ray images has facilitated the accurate diagnosis of COVID-19. In this study, we reviewed studies which used machine and deep learning methods on chest X-ray images and CT scans for COVID-19 diagnosis and compared their performance. The accuracy of these methods ranged from 76% to more than 99%, indicating the applicability of machine and deep learning methods in the clinical diagnosis of COVID-19.

A Few-Shot U-Net Deep Learning Model for COVID-19 Infected Area Segmentation in CT Images

Recent studies indicate that detecting radiographic patterns on CT chest scans can yield high sensitivity and specificity for COVID-19 identification. In this paper, we scrutinize the effectiveness of deep learning models for semantic segmentation of pneumonia-infected area segmentation in CT images for the detection of COVID-19. Traditional methods for CT scan segmentation exploit a supervised learning paradigm, so they (a) require large volumes of data for their training, and (b) assume fixed (static) network weights once the training procedure has been completed. Recently, to overcome these difficulties, few-shot learning (FSL) has been introduced as a general concept of network model training using a very small amount of samples. In this paper, we explore the efficacy of few-shot learning in U-Net architectures, allowing for a dynamic fine-tuning of the network weights as new few samples are being fed into the U-Net. Experimental results indicate improvement in the segmentation accuracy of identifying COVID-19 infected regions. In particular, using 4-fold cross-validation results of the different classifiers, we observed an improvement of 5.388 ± 3.046% for all test data regarding the IoU metric and a similar increment of 5.394 ± 3.015% for the F1 score. Moreover, the statistical significance of the improvement obtained using our proposed few-shot U-Net architecture compared with the traditional U-Net model was confirmed by applying the Kruskal-Wallis test (p-value = 0.026).

Development and Validation of a Deep Learning-Based Model to Distinguish Glioblastoma from Solitary Brain Metastasis Using Conventional MR Images

BACKGROUND AND PURPOSE

Differentiating glioblastoma from solitary brain metastasis preoperatively using conventional MR images is challenging. Deep learning models have shown promise in performing classification tasks. The diagnostic performance of a deep learning-based model in discriminating glioblastoma from solitary brain metastasis using preoperative conventional MR images was evaluated.

MATERIALS AND METHODS

Records of 598 patients with histologically confirmed glioblastoma or solitary brain metastasis at our institution between February 2006 and December 2017 were retrospectively reviewed. Preoperative contrast-enhanced T1WI and T2WI were preprocessed and roughly segmented with rectangular regions of interest. A deep neural network was trained and validated using MR images from 498 patients. The MR images of the remaining 100 were used as an internal test set. An additional 143 patients from another tertiary hospital were used as an external test set. The classifications of ResNet-50 and 2 neuroradiologists were compared for their accuracy, precision, recall, F1 score, and area under the curve.

RESULTS

The areas under the curve of ResNet-50 were 0.889 and 0.835 in the internal and external test sets, respectively. The area under the curve of neuroradiologists 1 and 2 were 0.889 and 0.768 in the internal test set and 0.857 and 0.708 in the external test set, respectively.

CONCLUSIONS

A deep learning-based model may be a supportive tool for preoperative discrimination between glioblastoma and solitary brain metastasis using conventional MR images.

Common pitfalls and recommendations for using machine learning to detect and prognosticate for COVID-19 using chest radiographs and CT scans

Machine learning methods offer great promise for fast and accurate detection and prognostication of coronavirus disease 2019 (COVID-19) from standard-of-care chest radiographs (CXR) and chest computed tomography (CT) images. Many articles have been published in 2020 describing new machine learning-based models for both of these tasks, but it is unclear which are of potential clinical utility. In this systematic review, we consider all published papers and preprints, for the period from 1 January 2020 to 3 October 2020, which describe new machine learning models for the diagnosis or prognosis of COVID-19 from CXR or CT images. All manuscripts uploaded to bioRxiv, medRxiv and arXiv along with all entries in EMBASE and MEDLINE in this timeframe are considered. Our search identified 2,212 studies, of which 415 were included after initial screening and, after quality screening, 62 studies were included in this systematic review. Our review finds that none of the models identified are of potential clinical use due to methodological flaws and/or underlying biases. This is a major weakness, given the urgency with which validated COVID-19 models are needed. To address this, we give many recommendations which, if followed, will solve these issues and lead to higher-quality model development and well-documented manuscripts.

Deep Learning in the Detection and Diagnosis of COVID-19 Using Radiology Modalities: A Systematic Review

Introduction

The early detection and diagnosis of COVID-19 and the accurate separation of non-COVID-19 cases at the lowest cost and in the early stages of the disease are among the main challenges in the current COVID-19 pandemic. Concerning the novelty of the disease, diagnostic methods based on radiological images suffer from shortcomings despite their many applications in diagnostic centers. Accordingly, medical and computer researchers tend to use machine-learning models to analyze radiology images. Material and Methods. The present systematic review was conducted by searching the three databases of PubMed, Scopus, and Web of Science from November 1, 2019, to July 20, 2020, based on a search strategy. A total of 168 articles were extracted and, by applying the inclusion and exclusion criteria, 37 articles were selected as the research population.

Result

This review study provides an overview of the current state of all models for the detection and diagnosis of COVID-19 through radiology modalities and their processing based on deep learning. According to the findings, deep learning-based models have an extraordinary capacity to offer an accurate and efficient system for the detection and diagnosis of COVID-19, the use of which in the processing of modalities would lead to a significant increase in sensitivity and specificity values.

Conclusion

The application of deep learning in the field of COVID-19 radiologic image processing reduces false-positive and negative errors in the detection and diagnosis of this disease and offers a unique opportunity to provide fast, cheap, and safe diagnostic services to patients.

A Vital Sign-based Prediction Algorithm for Differentiating COVID-19 Versus Seasonal Influenza in Hospitalized Patients

Patients with influenza and SARS-CoV2/Coronavirus disease 2019 (COVID-19) infections have different clinical course and outcomes. We developed and validated a supervised machine learning pipeline to distinguish the two viral infections using the available vital signs and demographic dataset from the first hospital/emergency room encounters of 3,883 patients who had confirmed diagnoses of influenza A/B, COVID-19 or negative laboratory test results. The models were able to achieve an area under the receiver operating characteristic curve (ROC AUC) of at least 97% using our multiclass classifier. The predictive models were externally validated on 15,697 encounters in 3,125 patients available on TrinetX database that contains patient-level data from different healthcare organizations. The influenza vs. COVID-19-positive model had an AUC of 98%, and 92% on the internal and external test sets, respectively. Our study illustrates the potentials of machine-learning models for accurately distinguishing the two viral infections. The code is made available at https://github.com/ynaveena/COVID-19-vs-Influenza and may be have utility as a frontline diagnostic tool to aid healthcare workers in triaging patients once the two viral infections start cocirculating in the communities.

Deep Learning-Driven Automated Detection of COVID-19 from Radiography Images: a Comparative Analysis

The COVID-19 pandemic has wreaked havoc on the whole world, taking over half a million lives and capsizing the world economy in unprecedented magnitudes. With the world scampering for a possible vaccine, early detection and containment are the only redress. Existing diagnostic technologies with high accuracy like RT-PCRs are expensive and sophisticated, requiring skilled individuals for specimen collection and screening, resulting in lower outreach. So, methods excluding direct human intervention are much sought after, and artificial intelligence-driven automated diagnosis, especially with radiography images, captured the researchers' interest. This survey marks a detailed inspection of the deep learning-based automated detection of COVID-19 works done to date, a comparison of the available datasets, methodical challenges like imbalanced datasets and others, along with probable solutions with different preprocessing methods, and scopes of future exploration in this arena. We also benchmarked the performance of 315 deep models in diagnosing COVID-19, normal, and pneumonia from X-ray images of a custom dataset created from four others. The dataset is publicly available at https://github.com/rgbnihal2/COVID-19-X-ray-Dataset. Our results show that DenseNet201 model with Quadratic SVM classifier performs the best (accuracy: 98.16%, sensitivity: 98.93%, specificity: 98.77%) and maintains high accuracies in other similar architectures as well. This proves that even though radiography images might not be conclusive for radiologists, but it is so for deep learning algorithms for detecting COVID-19. We hope this extensive review will provide a comprehensive guideline for researchers in this field.

Non-intubated video-assisted thoracic surgery for subxiphoid anterior mediastinal tumor resection

Background

Subxiphoid approach for mediastinal tumor resection was reported to provide a better view and less postoperative pain. Non-intubated video-assisted thoracic surgery (NI-VATS) without muscle relaxant would decrease the possibility of postoperative airway collapse for anterior mediastinal mass operation. Herein, we sought to describe the use of NI-VATS through subxiphoid approach for anterior mediastinal tumor resection.

Methods

In this retrospective cohort study, patients that underwent subxiphoid VATS resection for anterior mediastinal tumor between December 2015 and September 2019 were divided into two groups: NI-VATS and intubated VATS (I-VATS). Intraoperative and postoperative variables were compared.

Results

A total of 40 patients were included. Among them, 21 patients received NI-VATS (52.5%) and 19 were treated with I-VATS (47.5%). In total, intraoperative (4/21 vs. 2/19; P=0.446) and postoperative complications (5/21 vs. 7/19; P=0.369) were similar between NI-VATS and I-VATS group. The anesthesia time (231.76 vs. 244.71 min; P=0.218), the operation time (152.35 vs. 143.64 min; P=0.980), chest tube duration (1.81 vs. 1.84 days; P=0.08), the total volume (351.95 vs. 348.00 mL; P=0.223), post-operative pain scores (2.79 vs. 2.93, P=0.413), and the length of stay (9.47 vs. 10.57 days; P=0.970) were all comparable between two groups.

Conclusions

NI-VATS for mediastinal tumor resection via subxiphoid approach is a safe and technically feasible option in selected patients, which leads to comparable perioperative clinical outcomes when compared with I-VATS via the subxiphoid approach. This technique could be used as an alteration when intubation is not available.

A narrative review on characterization of acute respiratory distress syndrome in COVID-19-infected lungs using artificial intelligence

COVID-19 has infected 77.4 million people worldwide and has caused 1.7 million fatalities as of December 21, 2020. The primary cause of death due to COVID-19 is Acute Respiratory Distress Syndrome (ARDS). According to the World Health Organization (WHO), people who are at least 60 years old or have comorbidities that have primarily been targeted are at the highest risk from SARS-CoV-2. Medical imaging provides a non-invasive, touch-free, and relatively safer alternative tool for diagnosis during the current ongoing pandemic. Artificial intelligence (AI) scientists are developing several intelligent computer-aided diagnosis (CAD) tools in multiple imaging modalities, i.e., lung computed tomography (CT), chest X-rays, and lung ultrasounds. These AI tools assist the pulmonary and critical care clinicians through (a) faster detection of the presence of a virus, (b) classifying pneumonia types, and (c) measuring the severity of viral damage in COVID-19-infected patients. Thus, it is of the utmost importance to fully understand the requirements of for a fast and successful, and timely lung scans analysis. This narrative review first presents the pathological layout of the lungs in the COVID-19 scenario, followed by understanding and then explains the comorbid statistical distributions in the ARDS framework. The novelty of this review is the approach to classifying the AI models as per the by school of thought (SoTs), exhibiting based on segregation of techniques and their characteristics. The study also discusses the identification of AI models and its extension from non-ARDS lungs (pre-COVID-19) to ARDS lungs (post-COVID-19). Furthermore, it also presents AI workflow considerations of for medical imaging modalities in the COVID-19 framework. Finally, clinical AI design considerations will be discussed. We conclude that the design of the current existing AI models can be improved by considering comorbidity as an independent factor. Furthermore, ARDS post-processing clinical systems must involve include (i) the clinical validation and verification of AI-models, (ii) reliability and stability criteria, and (iii) easily adaptable, and (iv) generalization assessments of AI systems for their use in pulmonary, critical care, and radiological settings.

Coronavirus disease (COVID-19) detection in Chest X-Ray images using majority voting based classifier ensemble

Novel coronavirus disease (nCOVID-19) is the most challenging problem for the world. The disease is caused by severe acute respiratory syndrome coronavirus-2 (SARS-COV-2), leading to high morbidity and mortality worldwide. The study reveals that infected patients exhibit distinct radiographic visual characteristics along with fever, dry cough, fatigue, dyspnea, etc. Chest X-Ray (CXR) is one of the important, non-invasive clinical adjuncts that play an essential role in the detection of such visual responses associated with SARS-COV-2 infection. However, the limited availability of expert radiologists to interpret the CXR images and subtle appearance of disease radiographic responses remains the biggest bottlenecks in manual diagnosis. In this study, we present an automatic COVID screening (ACoS) system that uses radiomic texture descriptors extracted from CXR images to identify the normal, suspected, and nCOVID-19 infected patients. The proposed system uses two-phase classification approach (normal vs. abnormal and nCOVID-19 vs. pneumonia) using majority vote based classifier ensemble of five benchmark supervised classification algorithms. The training-testing and validation of the ACoS system are performed using 2088 (696 normal, 696 pneumonia and 696 nCOVID-19) and 258 (86 images of each category) CXR images, respectively. The obtained validation results for phase-I (accuracy (ACC) = 98.062%, area under curve (AUC) = 0.956) and phase-II (ACC = 91.329% and AUC = 0.831) show the promising performance of the proposed system. Further, the Friedman post-hoc multiple comparisons and z-test statistics reveals that the results of ACoS system are statistically significant. Finally, the obtained performance is compared with the existing state-of-the-art methods.

Multi-layer Representation Learning and Its Application to Electronic Health Records

Electronic Health Records (EHRs) are digital records associated with hospitalization, diagnosis, medications and so on. Secondary use of EHRs can promote the clinical informatics applications and the development of healthcare undertaking. EHRs have the unique characteristic where the patient visits are temporally ordered but the diagnosis codes within a visit are randomly ordered. The hierarchical structure requires a multi-layer network to explore the different relational information of EHRs. In this paper, we propose a Multi-Layer Representation Learning method (MLRL), which is capable of learning effective patient representation by hierarchically exploring the valuable information in both diagnosis codes and patient visits. Firstly, MLRL utilizes the multi-head attention mechanism to explore the potential connections in diagnosis codes, and a linear transformation is implemented to further map the code vectors to non-negative real-valued representations. The initial visit vectors are then obtained by summarizing all the code representations. Secondly, the proposed method combines Bidirectional Long Short-Term Memory with self-attention mechanism to learn the weighted visit vectors which are aggregated to form the patient representation. Finally, to evaluate the performance of MLRL, we apply it to patient's mortality prediction on real EHRs and the experimental results demonstrate that MLRL has a significant improvement in prediction performance. MLRL achieves around 0.915 in Area Under Curve which is superior to the results obtained by baseline methods. Furthermore, compared with raw data and other data representations, the learned representation with MLRL shows its outstanding results and availability on multiple different classifiers.

Fast and Accurate Detection of COVID-19 Along With 14 Other Chest Pathologies Using a Multi-Level Classification: Algorithm Development and Validation Study

BACKGROUND

COVID-19 has spread very rapidly, and it is important to build a system that can detect it in order to help an overwhelmed health care system. Many research studies on chest diseases rely on the strengths of deep learning techniques. Although some of these studies used state-of-the-art techniques and were able to deliver promising results, these techniques are not very useful if they can detect only one type of disease without detecting the others.

OBJECTIVE

The main objective of this study was to achieve a fast and more accurate diagnosis of COVID-19. This study proposes a diagnostic technique that classifies COVID-19 x-ray images from normal x-ray images and those specific to 14 other chest diseases.

METHODS

In this paper, we propose a novel, multilevel pipeline, based on deep learning models, to detect COVID-19 along with other chest diseases based on x-ray images. This pipeline reduces the burden of a single network to classify a large number of classes. The deep learning models used in this study were pretrained on the ImageNet dataset, and transfer learning was used for fast training. The lungs and heart were segmented from the whole x-ray images and passed onto the first classifier that checks whether the x-ray is normal, COVID-19 affected, or characteristic of another chest disease. If it is neither a COVID-19 x-ray image nor a normal one, then the second classifier comes into action and classifies the image as one of the other 14 diseases.

RESULTS

We show how our model uses state-of-the-art deep neural networks to achieve classification accuracy for COVID-19 along with 14 other chest diseases and normal cases based on x-ray images, which is competitive with currently used state-of-the-art models. Due to the lack of data in some classes such as COVID-19, we applied 10-fold cross-validation through the ResNet50 model. Our classification technique thus achieved an average training accuracy of 96.04% and test accuracy of 92.52% for the first level of classification (ie, 3 classes). For the second level of classification (ie, 14 classes), our technique achieved a maximum training accuracy of 88.52% and test accuracy of 66.634% by using ResNet50. We also found that when all the 16 classes were classified at once, the overall accuracy for COVID-19 detection decreased, which in the case of ResNet50 was 88.92% for training data and 71.905% for test data.

CONCLUSIONS

Our proposed pipeline can detect COVID-19 with a higher accuracy along with detecting 14 other chest diseases based on x-ray images. This is achieved by dividing the classification task into multiple steps rather than classifying them collectively.

A Review on Deep Learning Techniques for the Diagnosis of Novel Coronavirus (COVID-19)

Novel coronavirus (COVID-19) outbreak, has raised a calamitous situation all over the world and has become one of the most acute and severe ailments in the past hundred years. The prevalence rate of COVID-19 is rapidly rising every day throughout the globe. Although no vaccines for this pandemic have been discovered yet, deep learning techniques proved themselves to be a powerful tool in the arsenal used by clinicians for the automatic diagnosis of COVID-19. This paper aims to overview the recently developed systems based on deep learning techniques using different medical imaging modalities like Computer Tomography (CT) and X-ray. This review specifically discusses the systems developed for COVID-19 diagnosis using deep learning techniques and provides insights on well-known data sets used to train these networks. It also highlights the data partitioning techniques and various performance measures developed by researchers in this field. A taxonomy is drawn to categorize the recent works for proper insight. Finally, we conclude by addressing the challenges associated with the use of deep learning methods for COVID-19 detection and probable future trends in this research area. The aim of this paper is to facilitate experts (medical or otherwise) and technicians in understanding the ways deep learning techniques are used in this regard and how they can be potentially further utilized to combat the outbreak of COVID-19.

DeepCoroNet: A deep LSTM approach for automated detection of COVID-19 cases from chest X-ray images

The new coronavirus, known as COVID-19, first emerged in Wuhan, China, and since then has been transmitted to the whole world. Around 34 million people have been infected with COVID-19 virus so far, and nearly 1 million have died as a result of the virus. Resource shortages such as test kits and ventilator have arisen in many countries as the number of cases have increased beyond the control. Therefore, it has become very important to develop deep learning-based applications that automatically detect COVID-19 cases using chest X-ray images to assist specialists and radiologists in diagnosis. In this study, we propose a new approach based on deep LSTM model to automatically identify COVID-19 cases from X-ray images. Contrary to the transfer learning and deep feature extraction approaches, the deep LSTM model is an architecture, which is learned from scratch. Besides, the Sobel gradient and marker-controlled watershed segmentation operations are applied to raw images for increasing the performance of proposed model in the pre-processing stage. The experimental studies were performed on a combined public dataset constituted by gathering COVID-19, pneumonia and normal (healthy) chest X-ray images. The dataset was randomly separated into two sections as training and testing data. For training and testing, these separations were performed with the rates of 80%-20%, 70%-30% and 60%-40%, respectively. The best performance was achieved with 80% training and 20% testing rate. Moreover, the success rate was 100% for all performance criteria, which composed of accuracy, sensitivity, specificity and F-score. Consequently, the proposed model with pre-processing images ensured promising results on a small dataset compared to big data. Generally, the proposed model can significantly improve the present radiology based approaches and it can be very useful application for radiologists and specialists to help them in detection, quantity determination and tracing of COVID-19 cases throughout the pandemic.

InstaCovNet-19: A deep learning classification model for the detection of COVID-19 patients using Chest X-ray

Recently, the whole world became infected by the newly discovered coronavirus (COVID-19). SARS-CoV-2, or widely known as COVID-19, has proved to be a hazardous virus severely affecting the health of people. It causes respiratory illness, especially in people who already suffer from other diseases. Limited availability of test kits as well as symptoms similar to other diseases such as pneumonia has made this disease deadly, claiming the lives of millions of people. Artificial intelligence models are found to be very successful in the diagnosis of various diseases in the biomedical field In this paper, an integrated stacked deep convolution network InstaCovNet-19 is proposed. The proposed model makes use of various pre-trained models such as ResNet101, Xception, InceptionV3, MobileNet, and NASNet to compensate for a relatively small amount of training data. The proposed model detects COVID-19 and pneumonia by identifying the abnormalities caused by such diseases in Chest X-ray images of the person infected. The proposed model achieves an accuracy of 99.08% on 3 class (COVID-19, Pneumonia, Normal) classification while achieving an accuracy of 99.53% on 2 class (COVID, NON-COVID) classification. The proposed model achieves an average recall, F1 score, and precision of 99%, 99%, and 99%, respectively on ternary classification, while achieving a 100% precision and a recall of 99% on the binary class., while achieving a 100% precision and a recall of 99% on the COVID class. InstaCovNet-19's ability to detect COVID-19 without any human intervention at an economical cost with high accuracy can benefit humankind greatly in this age of Quarantine.

COVID-19 CT Image Synthesis With a Conditional Generative Adversarial Network

Coronavirus disease 2019 (COVID-19) is an ongoing global pandemic that has spread rapidly since December 2019. Real-time reverse transcription polymerase chain reaction (rRT-PCR) and chest computed tomography (CT) imaging both play an important role in COVID-19 diagnosis. Chest CT imaging offers the benefits of quick reporting, a low cost, and high sensitivity for the detection of pulmonary infection. Recently, deep-learning-based computer vision methods have demonstrated great promise for use in medical imaging applications, including X-rays, magnetic resonance imaging, and CT imaging. However, training a deep-learning model requires large volumes of data, and medical staff faces a high risk when collecting COVID-19 CT data due to the high infectivity of the disease. Another issue is the lack of experts available for data labeling. In order to meet the data requirements for COVID-19 CT imaging, we propose a CT image synthesis approach based on a conditional generative adversarial network that can effectively generate high-quality and realistic COVID-19 CT images for use in deep-learning-based medical imaging tasks. Experimental results show that the proposed method outperforms other state-of-the-art image synthesis methods with the generated COVID-19 CT images and indicates promising for various machine learning applications including semantic segmentation and classification.

Machine learning models for predicting critical illness risk in hospitalized patients with COVID-19 pneumonia

Background

To develop machine learning classifiers at admission for predicting which patients with coronavirus disease 2019 (COVID-19) who will progress to critical illness.

Methods

A total of 158 patients with laboratory-confirmed COVID-19 admitted to three designated hospitals between December 31, 2019 and March 31, 2020 were retrospectively collected. 27 clinical and laboratory variables of COVID-19 patients were collected from the medical records. A total of 201 quantitative CT features of COVID-19 pneumonia were extracted by using an artificial intelligence software. The critically ill cases were defined according to the COVID-19 guidelines. The least absolute shrinkage and selection operator (LASSO) logistic regression was used to select the predictors of critical illness from clinical and radiological features, respectively. Accordingly, we developed clinical and radiological models using the following machine learning classifiers, including naive bayes (NB), linear regression (LR), random forest (RF), extreme gradient boosting (XGBoost), adaptive boosting (AdaBoost), K-nearest neighbor (KNN), kernel support vector machine (k-SVM), and back propagation neural networks (BPNN). The combined model incorporating the selected clinical and radiological factors was also developed using the eight above-mentioned classifiers. The predictive efficiency of the models is validated using a 5-fold cross-validation method. The performance of the models was compared by the area under the receiver operating characteristic curve (AUC).

Results

The mean age of all patients was 58.9±13.9 years and 89 (56.3%) were males. 35 (22.2%) patients deteriorated to critical illness. After LASSO analysis, four clinical features including lymphocyte percentage, lactic dehydrogenase, neutrophil count, and D-dimer and four quantitative CT features were selected. The XGBoost-based clinical model yielded the highest AUC of 0.960 [95% confidence interval (CI): 0.913–1.000)]. The XGBoost-based radiological model achieved an AUC of 0.890 (95% CI: 0.757–1.000). However, the predictive efficacy of XGBoost-based combined model was very close to that of the XGBoost-based clinical model, with an AUC of 0.955 (95% CI: 0.906–1.000).

Conclusions

A XGBoost-based based clinical model on admission might be used as an effective tool to identify patients at high risk of critical illness.

Automatic Screening of COVID-19 Using an Optimized Generative Adversarial Network

The quick spread of coronavirus disease (COVID-19) has resulted in a global pandemic and more than fifteen million confirmed cases. To battle this spread, clinical imaging techniques, for example, computed tomography (CT), can be utilized for diagnosis. Automatic identification software tools are essential for helping to screen COVID-19 using CT images. However, there are few datasets available, making it difficult to train deep learning (DL) networks. To address this issue, a generative adversarial network (GAN) is proposed in this work to generate more CT images. The Whale Optimization Algorithm (WOA) is used to optimize the hyperparameters of GAN's generator. The proposed method is tested and validated with different classification and meta-heuristics algorithms using the SARS-CoV-2 CT-Scan dataset, consisting of COVID-19 and non-COVID-19 images. The performance metrics of the proposed optimized model, including accuracy (99.22%), sensitivity (99.78%), specificity (97.78%), F1-score (98.79%), positive predictive value (97.82%), and negative predictive value (99.77%), as well as its confusion matrix and receiver operating characteristic (ROC) curves, indicate that it performs better than state-of-the-art methods. This proposed model will help in the automatic screening of COVID-19 patients and decrease the burden on medicinal services frameworks.

Role of Machine Learning Techniques to Tackle the COVID-19 Crisis: Systematic Review

BACKGROUND

SARS-CoV-2, the novel coronavirus responsible for COVID-19, has caused havoc worldwide, with patients presenting a spectrum of complications that have pushed health care experts to explore new technological solutions and treatment plans. Artificial Intelligence (AI)-based technologies have played a substantial role in solving complex problems, and several organizations have been swift to adopt and customize these technologies in response to the challenges posed by the COVID-19 pandemic.

OBJECTIVE

The objective of this study was to conduct a systematic review of the literature on the role of AI as a comprehensive and decisive technology to fight the COVID-19 crisis in the fields of epidemiology, diagnosis, and disease progression.

METHODS

A systematic search of PubMed, Web of Science, and CINAHL databases was performed according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) guidelines to identify all potentially relevant studies published and made available online between December 1, 2019, and June 27, 2020. The search syntax was built using keywords specific to COVID-19 and AI.

RESULTS

The search strategy resulted in 419 articles published and made available online during the aforementioned period. Of these, 130 publications were selected for further analyses. These publications were classified into 3 themes based on AI applications employed to combat the COVID-19 crisis: Computational Epidemiology, Early Detection and Diagnosis, and Disease Progression. Of the 130 studies, 71 (54.6%) focused on predicting the COVID-19 outbreak, the impact of containment policies, and potential drug discoveries, which were classified under the Computational Epidemiology theme. Next, 40 of 130 (30.8%) studies that applied AI techniques to detect COVID-19 by using patients' radiological images or laboratory test results were classified under the Early Detection and Diagnosis theme. Finally, 19 of the 130 studies (14.6%) that focused on predicting disease progression, outcomes (ie, recovery and mortality), length of hospital stay, and number of days spent in the intensive care unit for patients with COVID-19 were classified under the Disease Progression theme.

CONCLUSIONS

In this systematic review, we assembled studies in the current COVID-19 literature that utilized AI-based methods to provide insights into different COVID-19 themes. Our findings highlight important variables, data types, and available COVID-19 resources that can assist in facilitating clinical and translational research.

Accurately Differentiating Between Patients With COVID-19, Patients With Other Viral Infections, and Healthy Individuals: Multimodal Late Fusion Learning Approach

BACKGROUND

Effectively identifying patients with COVID-19 using nonpolymerase chain reaction biomedical data is critical for achieving optimal clinical outcomes. Currently, there is a lack of comprehensive understanding in various biomedical features and appropriate analytical approaches for enabling the early detection and effective diagnosis of patients with COVID-19.

OBJECTIVE

We aimed to combine low-dimensional clinical and lab testing data, as well as high-dimensional computed tomography (CT) imaging data, to accurately differentiate between healthy individuals, patients with COVID-19, and patients with non-COVID viral pneumonia, especially at the early stage of infection.

METHODS

In this study, we recruited 214 patients with nonsevere COVID-19, 148 patients with severe COVID-19, 198 noninfected healthy participants, and 129 patients with non-COVID viral pneumonia. The participants' clinical information (ie, 23 features), lab testing results (ie, 10 features), and CT scans upon admission were acquired and used as 3 input feature modalities. To enable the late fusion of multimodal features, we constructed a deep learning model to extract a 10-feature high-level representation of CT scans. We then developed 3 machine learning models (ie, k-nearest neighbor, random forest, and support vector machine models) based on the combined 43 features from all 3 modalities to differentiate between the following 4 classes: nonsevere, severe, healthy, and viral pneumonia.

RESULTS

Multimodal features provided substantial performance gain from the use of any single feature modality. All 3 machine learning models had high overall prediction accuracy (95.4%-97.7%) and high class-specific prediction accuracy (90.6%-99.9%).

CONCLUSIONS

Compared to the existing binary classification benchmarks that are often focused on single-feature modality, this study's hybrid deep learning-machine learning framework provided a novel and effective breakthrough for clinical applications. Our findings, which come from a relatively large sample size, and analytical workflow will supplement and assist with clinical decision support for current COVID-19 diagnostic methods and other clinical applications with high-dimensional multimodal biomedical features.

Risk of in-hospital death associated with Covid-19 lung consolidations on chest computed tomography - A novel translational approach using a radiation oncology contour software

PURPOSE

To determine whether the percentage of lung involvement at the initial chest computed tomography (CT) is related to the subsequent risk of in-hospital death in patients with coronavirus disease-2019 (Covid-19).

MATERIALS AND METHODS

Using a cohort of 154 laboratory-confirmed Covid-19 pneumonia cases that underwent chest CT between February and April 2020, we performed a volumetric analysis of the lung opacities. The impact of relative lung involvement on outcomes was evaluated using multivariate logistic regression. The primary endpoint was the in-hospital mortality rate. The secondary endpoint was major adverse hospitalization events (intensive care unit admission, use of mechanical ventilation, or death).

RESULTS

The median age of the patients was 65 years: 50.6 % were male, and 36.4 % had a history of smoking. The median relative lung involvement was 28.8 % (interquartile range 9.5-50.3). The overall in-hospital mortality rate was 16.2 %. Thirty-six (26.3 %) patients were intubated. After adjusting for significant clinical factors, there was a 3.6 % increase in the chance of in-hospital mortality (OR 1.036; 95 % confidence interval, 1.010-1.063; P = 0.007) and a 2.5 % increase in major adverse hospital events (OR 1.025; 95 % confidence interval, 1.009-1.042; P = 0.002) per percentage unit of lung involvement. Advanced age (P = 0.013), DNR/DNI status at admission (P < 0.001) and smoking (P = 0.008) also increased in-hospital mortality. Older (P = 0.032) and male patients (P = 0.026) had an increased probability of major adverse hospitalization events.

CONCLUSIONS

Among patients hospitalized with Covid-19, more lung consolidation on chest CT increases the risk of in-hospital death, independently of confounding clinical factors.

Intelligent system for COVID-19 prognosis: a state-of-the-art survey

This 21st century is notable for experiencing so many disturbances at economic, social, cultural, and political levels in the entire world. The outbreak of novel corona virus 2019 (COVID-19) has been treated as a Public Health crisis of global Concern by the World Health Organization (WHO). Various outbreak models for COVID-19 are being utilized by researchers throughout the world to get well-versed decisions and impose significant control measures. Amid the standard methods for COVID-19 worldwide epidemic prediction, easy statistical, as well as epidemiological methods have got more consideration by researchers and authorities. One main difficulty in controlling the spreading of COVID-19 is the inadequacy and lack of medical tests for detecting as well as identifying a solution. To solve this problem, a few statistical-based advances are being enhanced and turn into a partial resolution up-to some level. To deal with the challenges of the medical field, a broad range of intelligent based methods, frameworks, and equipment have been recommended by Machine Learning (ML) and Deep Learning. As ML and DL have the ability of identifying and predicting patterns in complex large datasets, they are recognized as a suitable procedure for producing effective solutions for the diagnosis of COVID-19. In this paper, a perspective research has been conducted in the applicability of intelligent systems such as ML, DL and others in solving COVID-19 related outbreak issues. The main intention behind this study is (i) to understand the importance of intelligent approaches such as ML and DL for COVID-19 pandemic, (ii) discussing the efficiency and impact of these methods in the prognosis of COVID-19, (iii) the growth in the development of type of ML and advanced ML methods for COVID-19 prognosis,(iv) analyzing the impact of data types and the nature of data along with challenges in processing the data for COVID-19,(v) to focus on some future challenges in COVID-19 prognosis to inspire the researchers for innovating and enhancing their knowledge and research on other impacted sectors due to COVID-19.

Detecting SARS-CoV-2 From Chest X-Ray Using Artificial Intelligence

Chest radiographs (X-rays) combined with Deep Convolutional Neural Network (CNN) methods have been demonstrated to detect and diagnose the onset of COVID-19, the disease caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). However, questions remain regarding the accuracy of those methods as they are often challenged by limited datasets, performance legitimacy on imbalanced data, and have their results typically reported without proper confidence intervals. Considering the opportunity to address these issues, in this study, we propose and test six modified deep learning models, including VGG16, InceptionResNetV2, ResNet50, MobileNetV2, ResNet101, and VGG19 to detect SARS-CoV-2 infection from chest X-ray images. Results are evaluated in terms of accuracy, precision, recall, and f- score using a small and balanced dataset (Study One), and a larger and imbalanced dataset (Study Two). With 95% confidence interval, VGG16 and MobileNetV2 show that, on both datasets, the model could identify patients with COVID-19 symptoms with an accuracy of up to 100%. We also present a pilot test of VGG16 models on a multi-class dataset, showing promising results by achieving 91% accuracy in detecting COVID-19, normal, and Pneumonia patients. Furthermore, we demonstrated that poorly performing models in Study One (ResNet50 and ResNet101) had their accuracy rise from 70% to 93% once trained with the comparatively larger dataset of Study Two. Still, models like InceptionResNetV2 and VGG19's demonstrated an accuracy of 97% on both datasets, which posits the effectiveness of our proposed methods, ultimately presenting a reasonable and accessible alternative to identify patients with COVID-19.

Applications of artificial intelligence in battling against covid-19: A literature review

Colloquially known as coronavirus, the Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2), that causes CoronaVirus Disease 2019 (COVID-19), has become a matter of grave concern for every country around the world. The rapid growth of the pandemic has wreaked havoc and prompted the need for immediate reactions to curb the effects. To manage the problems, many research in a variety of area of science have started studying the issue. Artificial Intelligence is among the area of science that has found great applications in tackling the problem in many aspects. Here, we perform an overview on the applications of AI in a variety of fields including diagnosis of the disease via different types of tests and symptoms, monitoring patients, identifying severity of a patient, processing covid-19 related imaging tests, epidemiology, pharmaceutical studies, etc. The aim of this paper is to perform a comprehensive survey on the applications of AI in battling against the difficulties the outbreak has caused. Thus we cover every way that AI approaches have been employed and to cover all the research until the writing of this paper. We try organize the works in a way that overall picture is comprehensible. Such a picture, although full of details, is very helpful in understand where AI sits in current pandemonium. We also tried to conclude the paper with ideas on how the problems can be tackled in a better way and provide some suggestions for future works.

Covid-19 Imaging Tools: How Big Data is Big?

In this paper, considering year 2020 and Covid-19, we analyze medical imaging tools and their performance scores in accordance with the dataset size and their complexity. For this, we mainly consider AI-driven tools that employ two different types of image data, namely chest Computed Tomography (CT) and X-ray. We elaborate on their strengths and weaknesses by taking the following important factors into account: i) dataset size; ii) model fitting criteria (over-fitting and under-fitting); iii) transfer learning in the deep learning era; and iv) data augmentation. Medical imaging tools do not explicitly analyze model fitting. Also, using transfer learning, with fewer data, one could possibly build Covid-19 deep learning model but they are limited to education and training. We observe that, in both image modalities, neither the dataset size nor does data augmentation work well for Covid-19 screening purposes because a large dataset does not guarantee all possible Covid-19 manifestations and data augmentation does not create new Covid-19 cases.

CNN-based transfer learning-BiLSTM network: A novel approach for COVID-19 infection detection

Coronavirus disease 2019 (COVID-2019), which emerged in Wuhan, China in 2019 and has spread rapidly all over the world since the beginning of 2020, has infected millions of people and caused many deaths. For this pandemic, which is still in effect, mobilization has started all over the world, and various restrictions and precautions have been taken to prevent the spread of this disease. In addition, infected people must be identified in order to control the infection. However, due to the inadequate number of Reverse Transcription Polymerase Chain Reaction (RT-PCR) tests, Chest computed tomography (CT) becomes a popular tool to assist the diagnosis of COVID-19. In this study, two deep learning architectures have been proposed that automatically detect positive COVID-19 cases using Chest CT X-ray images. Lung segmentation (preprocessing) in CT images, which are given as input to these proposed architectures, is performed automatically with Artificial Neural Networks (ANN). Since both architectures contain AlexNet architecture, the recommended method is a transfer learning application. However, the second proposed architecture is a hybrid structure as it contains a Bidirectional Long Short-Term Memories (BiLSTM) layer, which also takes into account the temporal properties. While the COVID-19 classification accuracy of the first architecture is 98.14%, this value is 98.70% in the second hybrid architecture. The results prove that the proposed architecture shows outstanding success in infection detection and, therefore this study contributes to previous studies in terms of both deep architectural design and high classification success.

Diagnosis of COVID-19 Using Machine Learning and Deep Learning: A Review

BACKGROUND

This paper provides a systematic review of the application of Artificial Intelligence (AI) in the form of Machine Learning (ML) and Deep Learning (DL) techniques in fighting against the effects of novel coronavirus disease (COVID-19).

OBJECTIVE & METHODS

The objective is to perform a scoping review on AI for COVID-19 using preferred reporting items of systematic reviews and meta-analysis (PRISMA) guidelines. A literature search was performed for relevant studies published from 1 January 2020 till 27 March 2021. Out of 4050 research papers available in reputed publishers, a full-text review of 440 articles was done based on the keywords of AI, COVID-19, ML, forecasting, DL, X-ray, and Computed Tomography (CT). Finally, 52 articles were included in the result synthesis of this paper. As part of the review, different ML regression methods were reviewed first in predicting the number of confirmed and death cases. Secondly, a comprehensive survey was carried out on the use of ML in classifying COVID-19 patients. Thirdly, different datasets on medical imaging were compared in terms of the number of images, number of positive samples and number of classes in the datasets. The different stages of the diagnosis, including preprocessing, segmentation and feature extraction were also reviewed. Fourthly, the performance results of different research papers were compared to evaluate the effectiveness of DL methods on different datasets.

RESULTS

Results show that residual neural network (ResNet-18) and densely connected convolutional network (DenseNet 169) exhibit excellent classification accuracy for X-ray images, while DenseNet-201 has the maximum accuracy in classifying CT scan images. This indicates that ML and DL are useful tools in assisting researchers and medical professionals in predicting, screening and detecting COVID-19.

CONCLUSION

Finally, this review highlights the existing challenges, including regulations, noisy data, data privacy, and the lack of reliable large datasets, then provides future research directions in applying AI in managing COVID-19.

A novel comparative study for detection of Covid-19 on CT lung images using texture analysis, machine learning, and deep learning methods

The Covid-19 virus outbreak that emerged in China at the end of 2019 caused a huge and devastating effect worldwide. In patients with severe symptoms of the disease, pneumonia develops due to Covid-19 virus. This causes intense involvement and damage in lungs. Although the emergence of the disease occurred a short time ago, many literature studies have been carried out in which these effects of the disease on the lungs were revealed by the help of lung CT imaging. In this study, 1.396 lung CT images in total (386 Covid-19 and 1.010 Non-Covid-19) were subjected to automatic classification. In this study, Convolutional Neural Network (CNN), one of the deep learning methods, was used which suggested automatic classification of CT images of lungs for early diagnosis of Covid-19 disease. In addition, k-Nearest Neighbors (k-NN) and Support Vector Machine (SVM) was used to compare the classification successes of deep learning with machine learning. Within the scope of the study, a 23-layer CNN architecture was designed and used as a classifier. Also, training and testing processes were performed for Alexnet and Mobilenetv2 CNN architectures as well. The classification results were also calculated for the case of increasing the number of images used in training for the first 23-layer CNN architecture by 5, 10, and 20 times using data augmentation methods. To reveal the effect of the change in the number of images in the training and test clusters on the results, two different training and testing processes, 2-fold and 10-fold cross-validation, were performed and the results of the study were calculated. As a result, thanks to these detailed calculations performed within the scope of the study, a comprehensive comparison of the success of the texture analysis method, machine learning, and deep learning methods in Covid-19 classification from CT images was made. The highest mean sensitivity, specificity, accuracy, F-1 score, and AUC values obtained as a result of the study were 0,9197, 0,9891, 0,9473, 0,9058, 0,9888; respectively for 2-fold cross-validation, and they were 0,9404, 0,9901, 0,9599, 0,9284, 0,9903; respectively for 10-fold cross-validation.

Artificial Intelligence and technology in COVID Era: A narrative review

Application of artificial intelligence (AI) in the medical field during the coronavirus disease 2019 (COVID-19) era is being explored further due to its beneficial aspects such as self-reported data analysis, X-ray interpretation, computed tomography (CT) image recognition, and patient management. This narrative review article included published articles from MEDLINE/PubMed, Google Scholar and National Informatics Center egov mobile apps. The database was searched for "Artificial intelligence" and "COVID-19" and "respiratory care unit" written in the English language during a period of one year 2019-2020. The relevance of AI for patients is in hands of people with digital health tools, Aarogya setu app and Smartphone technology. AI shows about 95% accuracy in detecting COVID-19-specific chest findings. Robots with AI are being used for patient assessment and drug delivery to patients to avoid the spread of infection. The pandemic outbreak has replaced the classroom method of teaching with the online execution of teaching practices and simulators. AI algorithms have been used to develop major organ tissue characterization and intelligent pain management techniques for patients. The Blue-dot AI-based algorithm helps in providing early warning signs. The AI model automatically identifies a patient in respiratory distress based on face detection, face recognition, facial action unit detection, expression recognition, posture, extremity movement analysis, visitation frequency detection sound pressure, and light level detection. There is now no looking back as AI and machine learning are to stay in the field of training, teaching, patient care, and research in the future.

Independent role of CT chest scan in COVID-19 prognosis: Evidence from the machine learning classification

Background: The current coronavirus disease-19 (COVID-19) pandemic call attention to the key role informatics play in healthcare. The present study discovers an independent role of computerised tomography chest (CT) scans in prognosis of COVID-19 using classification learning algorithms. Methods: In this retrospective study, 57 RT PCR positive COVID-19 patients were enrolled from SMS Medical College, Jaipur (Rajasthan, India) after approval from the Institutional Ethics Committee. A set of 21 features including clinical findings and laboratory parameters and chest CT severity score were recorded. The CT score with mild, moderate and severe categories was chosen as response variable. The dimensionality reduction of feature space was performed and classifiers including, decision trees, K-nearest neighbours, support vector machine and ensemble learning were trained with principal components. The model with highest accuracy and area under the ROC curve (AUC) was selected. Results: The median age of patients was 55 years (range: 20-99 years) with 37 males. The feature space was reduced from 21 to 7 predictors, that included fever, cough, fibrin degradation products, haemoglobin, neutrophil-lymphocyte ratio, ferritin and procalcitonin. The linear support vector machine was chosen as the best classifier with 73.7 % and 0.69 accuracy and AUC for severe CT chest score, respectively. The variance contributed by first three principal components were 97.5 %, 2.4 % and 0.0 %, respectively. Conclusion: In view of low degree of relationships between predictors and chest CT scan severity score category as interpreted from accuracy and AUC it can be concluded that chest CT scan has an independent role in the prognosis of COVID-19 patients.

Transfer learning-based convolutional neural network for COVID-19 detection with X-ray images

Countries the world over have focused on protecting human health and combatting the COVID-19 outbreak. It has had a destructive effect on human health and daily life. Many people have been infected and have died. It is critical to control and prevent the spread of COVID-19 disease by applying quick alternative diagnostic techniques. Although laboratory tests have been widely applied as diagnostic tools, findings suggest that the application of X-ray and computed tomography images and pretrained deep convolutional neural network (CNN) models can help in the accurate detection of this disease. In this study, we propose a model for COVID-19 diagnosis, applying a deep CNN technique based on raw chest X-ray images of COVID-19 patients, which can be accessed publicly on GitHub. Fifty positive and 50 negative COVID-19 X-ray images for training and 20 positive and 20 negative images for testing phases are included. Because the classification of X-ray images needs a deep architecture to cope with the complicated structure of images, we apply five different architectures of well-known pretrained deep CNN models: VGG16, VGG19, ResNet, DenseNet, and InceptionV3. The pretrained VGG16 model can detect COVID-19 from non-COVID-19 cases with the highest classification performance of 80% accuracy among the other four proposed models, and it can be used as a helpful tool in the department of radiology. In the proposed model, a limited dataset of COVID-19 X-ray images is used that can provide more accurate performance when the number of instances in the dataset increases.

Acoustery System for Differential Diagnosing of Coronavirus COVID-19 Disease

Goal: Because of the outbreak of coronavirus infection, healthcare systems are faced with the lack of medical professionals. We present a system for the differential diagnosis of coronavirus disease, based on deep learning techniques, which can be implemented in clinics. Methods: A recurrent network with a convolutional neural network as an encoder and an attention mechanism is used. A database of about 3000 records of coughing was collected. The data was collected through the Acoustery mobile application in hospitals in Russia, Belarus, and Kazakhstan from April 2020 to October 2020. Results: The model classification accuracy reaches 85%. Values of precision and recall metrics are 78.5% and 73%. Conclusions: We reached satisfactory results in solving the problem. The proposed model is already being tested by doctors to understand the ways of improvement. Other architectures should be considered that use a larger training sample and all available patient information.

Predicting the COVID-19 infection with fourteen clinical features using machine learning classification algorithms

While the RT-PCR is the silver bullet test for confirming the COVID-19 infection, it is limited by the lack of reagents, time-consuming, and the need for specialized labs. As an alternative, most of the prior studies have focused on Chest CT images and Chest X-Ray images using deep learning algorithms. However, these two approaches cannot always be used for patients' screening due to the radiation doses, high costs, and the low number of available devices. Hence, there is a need for a less expensive and faster diagnostic model to identify the positive and negative cases of COVID-19. Therefore, this study develops six predictive models for COVID-19 diagnosis using six different classifiers (i.e., BayesNet, Logistic, IBk, CR, PART, and J48) based on 14 clinical features. This study retrospected 114 cases from the Taizhou hospital of Zhejiang Province in China. The results showed that the CR meta-classifier is the most accurate classifier for predicting the positive and negative COVID-19 cases with an accuracy of 84.21%. The results could help in the early diagnosis of COVID-19, specifically when the RT-PCR kits are not sufficient for testing the infection and assist countries, specifically the developing ones that suffer from the shortage of RT-PCR tests and specialized laboratories.

COVIDNet-CT: A Tailored Deep Convolutional Neural Network Design for Detection of COVID-19 Cases From Chest CT Images

The coronavirus disease 2019 (COVID-19) pandemic continues to have a tremendous impact on patients and healthcare systems around the world. In the fight against this novel disease, there is a pressing need for rapid and effective screening tools to identify patients infected with COVID-19, and to this end CT imaging has been proposed as one of the key screening methods which may be used as a complement to RT-PCR testing, particularly in situations where patients undergo routine CT scans for non-COVID-19 related reasons, patients have worsening respiratory status or developing complications that require expedited care, or patients are suspected to be COVID-19-positive but have negative RT-PCR test results. Early studies on CT-based screening have reported abnormalities in chest CT images which are characteristic of COVID-19 infection, but these abnormalities may be difficult to distinguish from abnormalities caused by other lung conditions. Motivated by this, in this study we introduce COVIDNet-CT, a deep convolutional neural network architecture that is tailored for detection of COVID-19 cases from chest CT images via a machine-driven design exploration approach. Additionally, we introduce COVIDx-CT, a benchmark CT image dataset derived from CT imaging data collected by the China National Center for Bioinformation comprising 104,009 images across 1,489 patient cases. Furthermore, in the interest of reliability and transparency, we leverage an explainability-driven performance validation strategy to investigate the decision-making behavior of COVIDNet-CT, and in doing so ensure that COVIDNet-CT makes predictions based on relevant indicators in CT images. Both COVIDNet-CT and the COVIDx-CT dataset are available to the general public in an open-source and open access manner as part of the COVID-Net initiative. While COVIDNet-CT is not yet a production-ready screening solution, we hope that releasing the model and dataset will encourage researchers, clinicians, and citizen data scientists alike to leverage and build upon them.

A Survey on Artificial Intelligence in Chest Imaging of COVID-19

Abstract The coronavirus disease 2019 (COVID-19) has infected more than 9.3 million people and has caused over 0.47 million deaths worldwide as of June 24, 2020. Chest imaging techniques including computed tomography and X-ray scans are indispensable tools in COVID-19 diagnosis and its management. The strong infectiousness of this disease brings a huge burden for radiologists. In order to overcome the difficulty and improve accuracy of the diagnosis, artificial intelligence (AI)-based imaging analysis methods are explored. This survey focuses on the development of chest imaging analysis methods based on AI for COVID-19 in the past few months. Specially, we first recall imaging analysis methods of two typical viral pneumonias, which can provide a reference for studying the disease on chest images. We further describe the development of AI-assisted diagnosis and assessment for the disease, and find that AI techniques have great advantage in this application.

Development and External Validation of a Machine Learning Tool to Rule Out COVID-19 Among Adults in the Emergency Department Using Routine Blood Tests: A Large, Multicenter, Real-World Study

Background

Conventional diagnosis of COVID-19 with reverse transcription polymerase chain reaction (RT-PCR) testing (hereafter, PCR) is associated with prolonged time to diagnosis and significant costs to run the test. The SARS-CoV-2 virus might lead to characteristic patterns in the results of widely available, routine blood tests that could be identified with machine learning methodologies. Machine learning modalities integrating findings from these common laboratory test results might accelerate ruling out COVID-19 in emergency department patients.

Objective

We sought to develop (ie, train and internally validate with cross-validation techniques) and externally validate a machine learning model to rule out COVID 19 using only routine blood tests among adults in emergency departments.

Methods

Using clinical data from emergency departments (EDs) from 66 US hospitals before the pandemic (before the end of December 2019) or during the pandemic (March-July 2020), we included patients aged ≥20 years in the study time frame. We excluded those with missing laboratory results. Model training used 2183 PCR-confirmed cases from 43 hospitals during the pandemic; negative controls were 10,000 prepandemic patients from the same hospitals. External validation used 23 hospitals with 1020 PCR-confirmed cases and 171,734 prepandemic negative controls. The main outcome was COVID 19 status predicted using same-day routine laboratory results. Model performance was assessed with area under the receiver operating characteristic (AUROC) curve as well as sensitivity, specificity, and negative predictive value (NPV).

Results

Of 192,779 patients included in the training, external validation, and sensitivity data sets (median age decile 50 [IQR 30-60] years, 40.5% male [78,249/192,779]), AUROC for training and external validation was 0.91 (95% CI 0.90-0.92). Using a risk score cutoff of 1.0 (out of 100) in the external validation data set, the model achieved sensitivity of 95.9% and specificity of 41.7%; with a cutoff of 2.0, sensitivity was 92.6% and specificity was 59.9%. At the cutoff of 2.0, the NPVs at a prevalence of 1%, 10%, and 20% were 99.9%, 98.6%, and 97%, respectively.

Conclusions

A machine learning model developed with multicenter clinical data integrating commonly collected ED laboratory data demonstrated high rule-out accuracy for COVID-19 status, and might inform selective use of PCR-based testing.

A Novel Medical Diagnosis model for COVID-19 infection detection based on Deep Features and Bayesian Optimization

A pneumonia of unknown causes, which was detected in Wuhan, China, and spread rapidly throughout the world, was declared as Coronavirus disease 2019 (COVID-19). Thousands of people have lost their lives to this disease. Its negative effects on public health are ongoing. In this study, an intelligence computer-aided model that can automatically detect positive COVID-19 cases is proposed to support daily clinical applications. The proposed model is based on the convolution neural network (CNN) architecture and can automatically reveal discriminative features on chest X-ray images through its convolution with rich filter families, abstraction, and weight-sharing characteristics. Contrary to the generally used transfer learning approach, the proposed deep CNN model was trained from scratch. Instead of the pre-trained CNNs, a novel serial network consisting of five convolution layers was designed. This CNN model was utilized as a deep feature extractor. The extracted deep discriminative features were used to feed the machine learning algorithms, which were k-nearest neighbor, support vector machine (SVM), and decision tree. The hyperparameters of the machine learning models were optimized using the Bayesian optimization algorithm. The experiments were conducted on a public COVID-19 radiology database. The database was divided into two parts as training and test sets with 70% and 30% rates, respectively. As a result, the most efficient results were ensured by the SVM classifier with an accuracy of 98.97%, a sensitivity of 89.39%, a specificity of 99.75%, and an F-score of 96.72%. Consequently, a cheap, fast, and reliable intelligence tool has been provided for COVID-19 infection detection. The developed model can be used to assist field specialists, physicians, and radiologists in the decision-making process. Thanks to the proposed tool, the misdiagnosis rates can be reduced, and the proposed model can be used as a retrospective evaluation tool to validate positive COVID-19 infection cases.

Multi-Time-Scale Features for Accurate Respiratory Sound Classification

The COVID-19 pandemic has amplified the urgency of the developments in computer-assisted medicine and, in particular, the need for automated tools supporting the clinical diagnosis and assessment of respiratory symptoms. This need was already clear to the scientific community, which launched an international challenge in 2017 at the International Conference on Biomedical Health Informatics (ICBHI) for the implementation of accurate algorithms for the classification of respiratory sound. In this work, we present a framework for respiratory sound classification based on two different kinds of features: (i) short-term features which summarize sound properties on a time scale of tenths of a second and (ii) long-term features which assess sounds properties on a time scale of seconds. Using the publicly available dataset provided by ICBHI, we cross-validated the classification performance of a neural network model over 6895 respiratory cycles and 126 subjects. The proposed model reached an accuracy of 85%±3% and an precision of 80%±8%, which compare well with the body of literature. The robustness of the predictions was assessed by comparison with state-of-the-art machine learning tools, such as the support vector machine, Random Forest and deep neural networks. The model presented here is therefore suitable for large-scale applications and for adoption in clinical practice. Finally, an interesting observation is that both short-term and long-term features are necessary for accurate classification, which could be the subject of future studies related to its clinical interpretation.

"Fast deep learning computer-aided diagnosis of COVID-19 based on digital chest x-ray images"

Coronavirus disease 2019 (COVID-19) is a novel harmful respiratory disease that has rapidly spread worldwide. At the end of 2019, COVID-19 emerged as a previously unknown respiratory disease in Wuhan, Hubei Province, China. The world health organization (WHO) declared the coronavirus outbreak a pandemic in the second week of March 2020. Simultaneous deep learning detection and classification of COVID-19 based on the full resolution of digital X-ray images is the key to efficiently assisting patients by enabling physicians to reach a fast and accurate diagnosis decision. In this paper, a simultaneous deep learning computer-aided diagnosis (CAD) system based on the YOLO predictor is proposed that can detect and diagnose COVID-19, differentiating it from eight other respiratory diseases: atelectasis, infiltration, pneumothorax, masses, effusion, pneumonia, cardiomegaly, and nodules. The proposed CAD system was assessed via five-fold tests for the multi-class prediction problem using two different databases of chest X-ray images: COVID-19 and ChestX-ray8. The proposed CAD system was trained with an annotated training set of 50,490 chest X-ray images. The regions on the entire X-ray images with lesions suspected of being due to COVID-19 were simultaneously detected and classified end-to-end via the proposed CAD predictor, achieving overall detection and classification accuracies of 96.31% and 97.40%, respectively. Most test images from patients with confirmed COVID-19 and other respiratory diseases were correctly predicted, achieving average intersection over union (IoU) greater than 90%. Applying deep learning regularizers of data balancing and augmentation improved the COVID-19 diagnostic performance by 6.64% and 12.17% in terms of the overall accuracy and the F1-score, respectively. It is feasible to achieve a diagnosis based on individual chest X-ray images with the proposed CAD system within 0.0093 s. Thus, the CAD system presented in this paper can make a prediction at the rate of 108 frames/s (FPS), which is close to real-time. The proposed deep learning CAD system can reliably differentiate COVID-19 from other respiratory diseases. The proposed deep learning model seems to be a reliable tool that can be used to practically assist health care systems, patients, and physicians.

Deep Transfer Learning for COVID-19 Prediction: Case Study for Limited Data Problems

OBJECTIVE

Automatic prediction of COVID-19 using deep convolution neural networks based pre-trained transfer models and Chest X-ray images.

METHODS

This research employs the advantages of computer vision and medical image analysis to develop an automated model that has the clinical potential for early detection of the disease. Using Deep Learning models, the research aims at evaluating the effectiveness and accuracy of different convolutional neural networks models in the automatic diagnosis of COVID-19 from X-ray images as compared to diagnosis performed by experts in the medical community.

RESULTS

Due to the fact that the dataset available for COVID-19 is still limited, the best model to use is the InceptionNetV3. Performance results show that the InceptionNetV3 model yielded the highest accuracy of 98.63% (with data augmentation) and 98.90% (without data augmentation) among the three models designed. However, as the dataset gets bigger, the Inception ResNetV2 and NASNetlarge will do a better job of classification. All the performed networks tend to over-fit when data augmentation is not used, this is due to the small amount of data used for training and validation.

CONCLUSION

A deep transfer learning is proposed to detecting the COVID-19 automatically from chest X-ray by training it with X-ray images gotten from both COVID-19 patients and people with normal chest X-rays. The study is aimed at helping doctors in making decisions in their clinical practice due its high performance and effectiveness, the study also gives an insight to how transfer learning was used to automatically detect the COVID-19.

Early survey with bibliometric analysis on machine learning approaches in controlling COVID-19 outbreaks

BACKGROUND AND OBJECTIVE

The COVID-19 pandemic has caused severe mortality across the globe, with the USA as the current epicenter of the COVID-19 epidemic even though the initial outbreak was in Wuhan, China. Many studies successfully applied machine learning to fight COVID-19 pandemic from a different perspective. To the best of the authors' knowledge, no comprehensive survey with bibliometric analysis has been conducted yet on the adoption of machine learning to fight COVID-19. Therefore, the main goal of this study is to bridge this gap by carrying out an in-depth survey with bibliometric analysis on the adoption of machine learning-based technologies to fight COVID-19 pandemic from a different perspective, including an extensive systematic literature review and bibliometric analysis.

METHODS

We applied a literature survey methodology to retrieved data from academic databases and subsequently employed a bibliometric technique to analyze the accessed records. Besides, the concise summary, sources of COVID-19 datasets, taxonomy, synthesis and analysis are presented in this study. It was found that the Convolutional Neural Network (CNN) is mainly utilized in developing COVID-19 diagnosis and prognosis tools, mostly from chest X-ray and chest CT scan images. Similarly, in this study, we performed a bibliometric analysis of machine learning-based COVID-19 related publications in the Scopus and Web of Science citation indexes. Finally, we propose a new perspective for solving the challenges identified as direction for future research. We believe the survey with bibliometric analysis can help researchers easily detect areas that require further development and identify potential collaborators.

RESULTS

The findings of the analysis presented in this article reveal that machine learning-based COVID-19 diagnose tools received the most considerable attention from researchers. Specifically, the analyses of results show that energy and resources are more dispenses towards COVID-19 automated diagnose tools while COVID-19 drugs and vaccine development remains grossly underexploited. Besides, the machine learning-based algorithm that is predominantly utilized by researchers in developing the diagnostic tool is CNN mainly from X-rays and CT scan images.

CONCLUSIONS

The challenges hindering practical work on the application of machine learning-based technologies to fight COVID-19 and new perspective to solve the identified problems are presented in this article. Furthermore, we believed that the presented survey with bibliometric analysis could make it easier for researchers to identify areas that need further development and possibly identify potential collaborators at author, country and institutional level, with the overall aim of furthering research in the focused area of machine learning application to disease control.

Nanotechnology-based promising strategies for the management of COVID-19: current development and constraints

INTRODUCTION

COVID-19 pandemic has been declared as a global emergency by the World Health Organization which has mounted global pressure on the healthcare system. The design and development of rapid tests for the precise and early detection of infection are urgently needed to detect the disease and also for bulk screening of infected persons. The traditional drugs moderately control the symptoms, but so far, no specific drug has been discovered. The prime concern is to device novel tools for rapid and precise diagnosis, drug delivery, and effective therapies for coronavirus. In this context, nanotechnology offers novel ways to fight against COVID-19.

AREA COVERED

This review includes the use of nanomaterials for the control of COVID-19. The tools for diagnosis of coronavirus, nano-based vaccines, and nanoparticles as a drug delivery system for the treatment of virus infection have been discussed. The toxicity issues related to nanoparticles have also been addressed.

EXPERT OPINION

The research on nanotechnology-based diagnosis, drug delivery, and antiviral therapies is at a preliminary stage. The antiviral nanomedicine therapies are cost-effective and with high quality. Nanoparticles are a promising tool for prevention, diagnosis, antiviral drug delivery, and therapeutics, which may open up new avenues in the treatment of COVID-19.